Log in to save to my catalogue
Log in to save to my catalogue

Ranibizumab Combined With Low-Dose Sorafenib for Exudative Age-Related Macular Degeneration

| Ask | Become a Library member

Ranibizumab Combined With Low-Dose Sorafenib for Exudative Age-Related Macular Degeneration

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_4065_83_2_231

Ranibizumab Combined With Low-Dose Sorafenib for Exudative Age-Related Macular Degeneration

About this item

Full title

Ranibizumab Combined With Low-Dose Sorafenib for Exudative Age-Related Macular Degeneration

Author / Creator

Diago, Teresa, MD , Pulido, Jose S., MD, MPH, MS , Molina, Julian R., MD, PhD , Collet, Lucienne C., MD , Link, Thomas P., CRA and Ryan, Edwin H., MD

Journal title

Mayo Clinic proceedings, 2008, Vol.83 (2), p.231-234

Language

English

Formats

Articles

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Angiogenesis is a common factor in the pathogenesis of cancer and in exudative age-related macular degeneration (AMD). Therefore, angiogenesis inhibition has been developed as a therapeutic strategy. We report 2 cases of recurrent exudative AMD in which oral sorafenib, a tyrosine kinase inhibitor approved for cancer, was added to intravitreal ranib...

Alternative Titles

Full title

Ranibizumab Combined With Low-Dose Sorafenib for Exudative Age-Related Macular Degeneration

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_4065_83_2_231

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_4065_83_2_231

Other Identifiers

ISSN

0025-6196

DOI

10.4065/83.2.231

How to access this item

Log in as a Library member

Full text available

View in old catalogue

Connecting people and collections